Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.31

-0.28

-0.25

-0.22

Details

Expected EPS

-0.26182580764

Actual EPS

-0.2316002

Surprise EPS

0.03

Surprise Percent

+11.54%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.2316002 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.